Chapter 1. HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-121 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET– By Type

6.1. Type I Hereditary Angioedema

6.2. Type II Hereditary Angioedema

6.3. Type III Hereditary Angioedema

Chapter 7. HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET– By Drug Class

7.1. C1-Esterase Inhibitor

7.2. Bradykinin B2 Receptor Antagonist

7.3. Kallikrein Inhibitor

7.4. Others

Chapter 8. HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET– By Treatment Type

8.1. Prophylaxis Treatment

8.2. On-demand Treatment

Chapter 9. HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET– By Route of Administration

9.1. Intravenous

9.2. Subcutaneous

9.3. Oral

Chapter 10. HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET– By End User

10.1. Hospitals

10.2. Clinics

10.3. Home Healthcare

10.4. Others

Chapter 11. HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET– By Region

11.1. North America

11.2. Europe

11.3. The Asia Pacific

11.4. Latin America

11.5. Middle-East and Africa

Chapter 12. HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

12.1. Company 1

12.2. Company 2

12.3. Company 3

12.4. Company 4

12.5. Company 5

12.6. Company 6

12.7. Company 7

12.8. Company 8

12.9. Company 9

12.10. Company 10

Download Sample